Cannabix Attending National Marijuana Business C

Cannabix Attending National Marijuana Business Conference and Update

For immediate release. Vancouver, British Columbia, October 14, 2014:Cannabix Technologies Inc.(CSE: BLO
, OTC PINK: BLOZF
) (the “Company”) will be attending the 3rd Annual National Marijuana Business Conference and Expo
November 12-14th, 2014 in Las Vegas, NV. As the largest and oldest national trade show for the legal cannabis and medical marijuana industry, the Marijuana Business Conference & Expo attracts attendees from more than 30 states and 10 countries. The Conference will feature 60 expert speakers with over 125 exhibits that will cover virtually every part of this growing industry.

Kal Malhi, President of Cannabix Technologies Inc. stated, “We look forward to attending this sold out conference and marketing Cannabix to industry professionals. We are seeing increasing interest in our device and a ramp up in national attention on the marijuana industry as Alaska, Oregon, Washington, D.C., and Florida will look to vote on legalization of marijuana in their respective states in November. Cannabix is progressing well on its prototype development of its marijuana breathalyzer. The Company and its engineering contractor KLN Klein are designing a feature rich hand-held device for law enforcement. Development has been systematically moving forward with electronics hardware, circuit board development, software development and procurement of parts for the assembly of the first prototype unit.”

About Cannabix Technologies Inc.

Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed in Sweden that has been clinically researched to be successful in testing individuals for recent consumption of the THC component of marijuana. Cannabix Technologies Inc. is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in various jurisdictions. Cannabix Technologies Inc. is working to develop the Cannabix Breathalyzer device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.

We seek Safe Harbor.

On behalf of the Board of Directors

“Rav Mlait”

CEO
Cannabix Technologies Inc.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking information that involves various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company, such as final development of a commercial or prototype product(s), successful trial or pilot of company technologies, no assurance that commercial sales of any kind actually materialize; no assurance the Company will have sufficient funds to complete product development. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; (ii) risks regarding protection of proprietary technology; (iii) the ability of the Company to complete financings; (v) the ability of the Company to develop and market its future product; and (vi) risks regarding government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company's public announcements and filings. There is no assurance that the marijuana breathalyzer business will provide any benefit to the Company, and no assurance that any proposed new products will be built or proceed. There is no assurance that existing “patent pending” technologies licensed by the Company will receive patent status by regulatory authorities. The Company is not currently selling commercial breathalyzers. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.

Neither CSE nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Contact
For additional information on Cannabix Technologies Inc. please visit our website at http://www.cannabixtechnologies.com
or email info@cannabixtechnologies.com